Announce Date | 05/07/2025 |
EPS Normalized Actual | $-2.06747 (Miss by $-2.77047) |
EPS GAAP Actual | $-2.06747 (Miss by $-2.77047) |
Revenue Actual | $112.895B |
Revenue Surprise | Beat by $112895M |
Announce Date | 08/28/2025 (Pre-Market) |
EPS Normalized Estimate | $0.71091 |
EPS GAAP Estimate | $0.71091 |
Revenue Estimate | $0.032461787B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | -0.07 | -0.7725 | 112.895B | 100% | 112862.15M |
FQ4 2024 (Nov 2024) | 0.64 | -0.22451 | 35.8786B | 100% | 35843.34M |
FQ3 2024 (Aug 2024) | 0 | -1.53737 | 43.0034B | 100% | 42962.53M |
FQ2 2013 (May 2013) | 0.8 | 0.8 | 0.00601776B | 100% | 6.02M |
FQ3 2013 (Aug 2013) | -0.0087 | -0.0087 | 0.00538771B | 100% | 5.39M |
FQ4 2013 (Nov 2013) | 0.26 | 0.26 | 0.00580122B | 100% | 5.8M |
FQ1 2014 (Feb 2014) | 0.65 | 0.65 | 0.00568706B | 100% | 5.69M |
FQ2 2014 (May 2014) | 0.33 | 0.33 | 0.00614412B | 2.06% | 6.14M |
FQ4 Announce Date
08/28/2025 (Pre-Market)
Consensus EPS Estimates
0.71091
Consensus Revenue Estimates
0.032461787B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 0.65367 | -- | 0.65367 | 0.65367 | 1 |
FQ4 2026 (Nov 2026) | 0.67963 | -- | 0.67963 | 0.67963 | 1 |
FQ3 2026 (Aug 2026) | 0.67265 | -- | 0.67265 | 0.67265 | 1 |
FQ2 2026 (May 2026) | 0.67255 | -- | 0.67255 | 0.67255 | 1 |
FQ1 2026 (Feb 2026) | 0.65169 | 110.74 | 0.65169 | 0.65169 | 1 |
FQ4 2025 (Nov 2025) | 0.70549 | 9.28 | 0.70549 | 0.70549 | 1 |
FQ3 2025 (Aug 2025) | 0.71091 | -- | 0.71091 | 0.71091 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ4 2026 (Nov 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ3 2026 (Aug 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ2 2026 (May 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ1 2026 (Feb 2026) | 0.03B | -347194.26 | 0.03B | 0.03B | 1 |
FQ4 2025 (Nov 2025) | 0.03B | -109775.04 | 0.03B | 0.03B | 1 |
FQ3 2025 (Aug 2025) | 0.03B | -132373.91 | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 0.7025 | -0.07 | -0.7725 | 1103.57% |
FQ4 2024 (Nov 2024) | 0.86451 | 0.64 | -0.22451 | -35.08% |
FQ3 2024 (Aug 2024) | 1.53737 | 0 | -1.53737 | -INF% |
FQ2 2013 (May 2013) | 0.8 | 0.8 | 100% | |
FQ3 2013 (Aug 2013) | -0.0087 | -0.0087 | 100% | |
FQ4 2013 (Nov 2013) | 0.26 | 0.26 | 100% | |
FQ1 2014 (Feb 2014) | 0.65 | 0.65 | 100% | |
FQ2 2014 (May 2014) | 0.33 | 0.33 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0.03B | $112.9B | $112862.15M | 99.97% |
FQ4 2024 (Nov 2024) | $0.04B | $35.88B | $35843.34M | 99.9% |
FQ3 2024 (Aug 2024) | $0.04B | $43B | $42962.53M | 99.9% |
FQ2 2013 (May 2013) | $0B | $0.01B | $6.02M | 100% |
FQ3 2013 (Aug 2013) | $0B | $0.01B | $5.39M | 100% |
FQ4 2013 (Nov 2013) | $0B | $0.01B | $5.8M | 100% |
FQ1 2014 (Feb 2014) | $0B | $0.01B | $5.69M | 100% |
FQ2 2014 (May 2014) | $0B | $0.01B | $6.14M | 100% |